Pharma Industry Buzz

Today's Top Business News from 1,000 SourcesSubscribe

Half Of Americans Are Taking Prescription Meds

Pharmalot - 1 day 12 hours 48 minutes ago

More than 48 percent of all Americans took at least one prescription drug each month in 2008, which amounts to a 10 percent increase over the previous decade, according to a new report from the US...
Web Buzz:
- DailyFinance - Almost Half of All Americans Are on Drugs
- PharmaTimes - 70% rise in Americans using five or more Rx drugs per month
How Allergan Sponsored a History of Sausages to Promote Botox Illegally

BNET Pharma - 2 days 8 hours 10 minutes ago

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism...
Web Buzz:
- PharmaTimes - Allergan pays $600M to settle Botox illegal promotion case
- Medical Marketing and Media - Allergan drops FDA lawsuit as part of off-label settlement
Companies Mentioned:

Allergan Inc.
Celldex Shares Tank as Pfizer Terminates Partnership to Develop Brain Cancer Vaccine

DailyFinance - 2 days 10 hours 23 minutes ago

Celldex Therapeutics' (CLDX) shares slumped over 30% Friday to $3.28 after it said it would regain full worldwide rights to its experimental therapeutic brain cancer vaccine rindopepimut,...
Web Buzz:
- BusinessWeek - Celldex Plunges After Pfizer Ends Cancer Vaccine Pact
- MarketWatch - Biotech Stocks: Celldex plunges; drug stock indexes climb
Companies Mentioned:

Pfizer Inc.
Pfizer Ends Pact With Celldex for Brain Tumor Vaccine

BusinessWeek - 2 days 12 hours 28 minutes ago

Sept. 3 (Bloomberg) -- Pfizer Inc. is pulling out of an agreement with Celldex Therapeutics Inc. to fund the development of an experimental brain tumor vaccine. Celldex shares fell the most in...
Web Buzz:
- The Boston Globe - Pfizer terminates agreement, Celldex says
- xonomy - Pfizer, Celldex Deal Ends
Companies Mentioned:

Pfizer Inc. Celldex Therapeutics Inc.
Roche launches restructuring plan | Swisster

PharmaGossip - 2 days 13 hours 16 minutes ago

Roche launches restructuring plan | Swisster : "Swiss pharmaceutical giant, Roche announced the launch of a what it called a 'Group-wide Operational Excellence initiative' on Friday 'in view of...
Web Buzz:
- PharmaTimes - Roche to cut costs across group, coy on job cut numbers
- DailyFinance - Roche Announces Cost-Cutting Plan
Companies Mentioned:

Roche Holding AG
NEJM fuels calls to withdraw Abbott's Meridia

FiercePharma - 3 days 12 hours 51 minutes ago

FEATURES >> The most interesting logos in Pharma Get ready for more controversy over Abbott Laboratories' (NYSE: ABT) diet pill Meridia. Two weeks before an FDA advisory panel meets to consider...
Web Buzz:
- Pharmalot - Should The FDA Have Moved Faster On Meridia?
- BusinessWeek - Abbott’s Meridia Raises Heart, Stroke Risk
Companies Mentioned:

FDA Abbott Laboratories Inc.
Another Japanese Drugmaker Buys Into Diet Pills

Pharmalot - 3 days 13 hours 37 minutes ago

For the second time this summer, a Japanese drugmaker has agreed to pay $50 million upfront for the rights to a forthcoming diet pill. This time, Takeda Pharmaceuticals is giving Orexigen...
Web Buzz:
- FierceBiotech - Orexigen and Takeda ink a billion-dollar pact on weight loss drug
- DailyFinance - Orexigen Shares Soar on Partnership Deal With Takeda
Companies Mentioned:

FDA
Pfizer to buy FoldRx Pharma

PharmaTimes - 3 days 15 hours 15 minutes ago

Specific financial terms were not disclosed, but the deal consists of an upfront payment and contingent payments if certain milestones are achieved. For the cash, Pfizer will bag investigational...
Web Buzz:
- The Boston Globe - Pfizer buying FoldRx for undisclosed amount
- Minnapolis Star Tribune - Pfizer buying FoldRx for undisclosed amount, expands development pipeline
- FierceBiotech - Pfizer buys FoldRx for rare disease division
Companies Mentioned:

Pfizer Inc.
Maker of Botox Settles Inquiry on Off-Label Use

New York Times - 3 days 20 hours 47 minutes ago

Allergan, the maker of Botox, agreed on Wednesday to pay $600 million to settle charges that it illegally promoted and sold the drug through 2005 for unapproved uses like treating...
Web Buzz:
- Wall Street Journal - Allergan to Settle Botox Charges
- New York Times: World Business - Maker of Botox Settles Inquiry
Companies Mentioned:

Allergan Inc.
Botox maker to pay $600M to resolve investigation

AOL News - 3 days 21 hours 48 minutes ago

WASHINGTON -Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based...
Web Buzz:
- Herald Sun - Botox maker to pay $674m
- TheStreet.com - Allergan, Xbox Live: Hot Trends
- The Times - Botox maker to pay $600m for off label misuse
- USA Today - Botox maker to pay $600M to resolve federal investigation
Companies Mentioned:

Allergan Inc. FDA
Pfizer Agrees To Acquire Drug Developer FoldRx

FOXBusiness.com - 3 days 22 hours 38 minutes ago

Pfizer Inc. (PFE) agreed to acquire privately held FoldRx Pharmaceuticals, whose leading drug candidate is a therapy for a genetic neurodegenerative disease for which the only current therapy is...
Web Buzz:
- Bloomberg - Pfizer Agrees to Acquire FoldRx in Rare-Disease Treatment Expansion Effort
- Bloomberg Businessweek - Pfizer To Buy FoldRx in Rare-Disease Drug Expansion
Companies Mentioned:

Pfizer Inc. FoldRx
Report: Burger King in talks to be acquired

Minnapolis Star Tribune - 3 days 22 hours 44 minutes ago

Burger King Holdings Inc. is in advanced talks to sell itself to 3G Capital, a little-known investment firm backed by wealthy Brazilian dealmakers who also control a large stake in the world's...
Web Buzz:
- Minnapolis Star Tribune - Couche Tard raises buyout offer for Casey's, which says it will review it
- Montreal Gazette - Couche-Tard further sweetens bid to buy Casey's
- Montreal Gazette - Couche-tard extending the date of its tender offer
Companies Mentioned:

Allergan Inc. Burger King Corp. Berkshire Hathaway Inc.
Botox Maker to Pay $600M to Settle Federal Probe

CBS News - 4 days 5 hours 31 minutes ago

(AP) Allergan Inc., the maker of wrinkle-smoothing Botox, says it will pay $600 million to settle a five-year-long federal investigation into its marketing of the top-selling, botulin-based...
Web Buzz:
- Reuters - Allergan to pay $600 million to settle Botox probe
- Pharmalot - Allergan Pays $600M To Settle Federal Botox Probe
Companies Mentioned:

Allergan Inc. FDA
Botox Maker Settles Case

New York Times - 4 days 8 hours 36 minutes ago

By NATASHA SINGER The specialty pharmaceutical company Allergan has agreed to pay $600 million to settle civil and criminal allegations that it illegally marketed Botox, the drug used in...
Web Buzz:
- BusinessWeek - Allergan Will Pay Fine, Plead Guilty to Misdemeanor
- PharmaGossip - Allergan Will Pay Fine, Plead Guilty to Misdemeanor in Botox Case - Bloomberg
Companies Mentioned:

Allergan Inc.
Genzyme CEO open to sale, not at $69 a share

Reuters - 4 days 16 hours 42 minutes ago

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.A sign marks the headquarters of Genzyme...
Web Buzz:
- BusinessWeek - Genzyme Chief Says He’ll Sell at ‘Fair Value,’ Not $69-a-Share
- Boston Business Journal - Genzyme investor to board: play ball
- Forbes - Genzyme Stiffarms Sanofi
- BBC - Genzyme spurns Sanofi buyout bid
- Mass High Tech - Genzyme investor backs buyout talks with Sanofi-Aventis
Companies Mentioned:

Genzyme Corp.
Paper: Roche mulls 'massive' worldwide job cuts

FiercePharma - 4 days 19 hours 14 minutes ago

FEATURES >> The most interesting logos in Pharma Is Big Pharma due for another layoff? That's what the Swiss newspaper Sonntag is reporting, saying that Roche is putting the final touches on a...
Web Buzz:
- PharmaGossip - Roche coy on job cut reports | InPharm
- Pharmalot - Is Roche Planning ‘Massive’ Job Cuts?
Companies Mentioned:

Roche Holding AG
The Race to Replace Warfarin

New York Times - 5 days 24 minutes ago

By NATASHA SINGER Updated: For investors who have been asking themselves whether medium-size pharmaceutical companies can survive in an industry that has seen recent mega-mergers, the answer...
Web Buzz:
- New York Times - New Rivals to Warfarin as Blood Clot Preventer
- FierceBiotech - Apixaban, Xarelto deliver good results in studies
Companies Mentioned:

Bristol-Myers Squibb Co.
Genzyme shareholders may hold buyout decision

Mass High Tech - 5 days 9 hours 15 minutes ago

French drug maker Sanofi-Aventis has promised to take its acquisition bid for Genzyme Corp. to its shareholders, after Genzyme management dismissed its offer of $69 per share. Genzyme has said it...
Web Buzz:
- The Boston Globe - Genzyme CEO says sale possible, at the right price
- Boston Business Journal - Genzyme investors hold cards
Companies Mentioned:

Genzyme Corp.
Stopping The Bleeding: Bloodthinner Study Results

Pharmalot - 5 days 14 hours 14 minutes ago

The battle to prevent blood clots is heating up this week as several drugmakers begin releasing study results for their experimental drugs. At stake, of course, is a huge market for stroke...
Web Buzz:
- New York Times - Companies Hurry to Develop Drugs to Prevent Blood Clotting
- BusinessWeek - Pfizer, Bayer Fight to Replace Rat Poison in Stroke-Drug Market
Companies Mentioned:

Pfizer Inc.
Stocks dip as investors enter week cautiously

AOL News - 5 days 23 hours 13 minutes ago

Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by...
Web Buzz:
- RTTNews.com - Stocks Mostly Lower In Mid-Morning Trading - U.S. Commentary
- RTTNews.com - Weakness Remains Visible On Wall Street In Early Afternoon Trading - U.S. Commentary
Companies Mentioned:

Genzyme Corp.

Page 1 of 60

All News Feed

From the top Industry sources

Suggest a Source
Source Opt Out

Today on MoneyWatch

Shopping? 4 Things
Not to Buy at Target

DVDs & more: Within these categories, you are likely to find better deals (or better products) elsewhere.

Most Popular

Office Nut Cases: A Field Guide

10 Things You Wish You Could Tell Your Boss

The Two Things Obama Needs to Say to Business

The 7 Interview Questions You Must Ask

Why an MBA Is a Waste of Time and Money

About BNET

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Pharma Industry Buzz

Half Of Americans Are Taking Prescription Meds

How Allergan Sponsored a History of Sausages to Promote Botox Illegally

Celldex Shares Tank as Pfizer Terminates Partnership to Develop Brain Cancer Vaccine

Pfizer Ends Pact With Celldex for Brain Tumor Vaccine

Roche launches restructuring plan | Swisster

NEJM fuels calls to withdraw Abbott's Meridia

Another Japanese Drugmaker Buys Into Diet Pills

Pfizer to buy FoldRx Pharma

Maker of Botox Settles Inquiry on Off-Label Use

Botox maker to pay $600M to resolve investigation

Pfizer Agrees To Acquire Drug Developer FoldRx

Report: Burger King in talks to be acquired

Botox Maker to Pay $600M to Settle Federal Probe

Botox Maker Settles Case

Genzyme CEO open to sale, not at $69 a share

Paper: Roche mulls 'massive' worldwide job cuts

The Race to Replace Warfarin

Genzyme shareholders may hold buyout decision

Stopping The Bleeding: Bloodthinner Study Results

Stocks dip as investors enter week cautiously

All News Feed

Today on MoneyWatch

Shopping? 4 Things
Not to Buy at Target

More on Moneywatch

Most Popular

About BNET

Featured Articles

Do These Applicants Even Want a Job?

Golf: The Global Language of Business

Vintage Bike Shop Thrives (Video)

Services

International